Proto Labs Balance Sheet Health
Financial Health criteria checks 6/6
Proto Labs has a total shareholder equity of $695.3M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $772.4M and $77.1M respectively. Proto Labs's EBIT is $28.4M making its interest coverage ratio -12.9. It has cash and short-term investments of $102.8M.
Key information
0%
Debt to equity ratio
US$0
Debt
Interest coverage ratio | -12.9x |
Cash | US$102.80m |
Equity | US$695.30m |
Total liabilities | US$77.06m |
Total assets | US$772.35m |
Recent financial health updates
No updates
Recent updates
Proto Labs: Cash Flows Are Supporting The Stock
Mar 04Proto Labs: Excellent Business Feats Yet To Financially Materialize
Feb 16Proto Labs (NYSE:PRLB) May Have Issues Allocating Its Capital
Jan 03Proto Labs: Overlooked Digital Manufacturing Opportunity
Dec 04Proto Labs Remains Profitable Despite So Much Pessimism
Sep 25Proto Labs: The Rally Appears Overdone
Jul 14Be Wary Of Proto Labs (NYSE:PRLB) And Its Returns On Capital
Jul 13Is There An Opportunity With Proto Labs, Inc.'s (NYSE:PRLB) 41% Undervaluation?
May 06Proto Labs (NYSE:PRLB) Might Be Having Difficulty Using Its Capital Effectively
Apr 08Proto Labs Non-GAAP EPS of $0.26 beats by $0.05, revenue of $115.6M beats by $5.47M
Feb 10Proto Labs: Transitioning From A Fast Grower To A Slow Grower
Jan 20Some Investors May Be Worried About Proto Labs' (NYSE:PRLB) Returns On Capital
Dec 21Proto Labs Q3 2022 Earnings Preview
Nov 03Proto Labs: Improvement Of The Digital Model And Undervalued
Oct 27Is It Too Late To Consider Buying Proto Labs, Inc. (NYSE:PRLB)?
Sep 12Protolabs names new technology chief
Sep 08Some Investors May Be Worried About Proto Labs' (NYSE:PRLB) Returns On Capital
Aug 05Proto Labs Q2 2022 Earnings Preview
Aug 04Proto Labs: Not A Great Prospect Until Profitability Issues Clear Up
Jul 07Is Proto Labs, Inc. (NYSE:PRLB) Potentially Undervalued?
May 24Proto Labs (NYSE:PRLB) Could Be Struggling To Allocate Capital
Mar 30The Prognosis For Proto Labs
Feb 22Returns On Capital At Proto Labs (NYSE:PRLB) Paint A Concerning Picture
Nov 28Is There Now An Opportunity In Proto Labs, Inc. (NYSE:PRLB)?
Nov 10Proto Labs: A Play On Additive Manufacturing
Nov 04Investors Could Be Concerned With Proto Labs' (NYSE:PRLB) Returns On Capital
Aug 29Some Investors May Be Willing To Look Past Proto Labs' (NYSE:PRLB) Soft Earnings
Aug 14Estimating The Fair Value Of Proto Labs, Inc. (NYSE:PRLB)
Aug 04Proto Labs: Bringing E-Commerce To Manufacturing
Jul 19What Is Proto Labs, Inc.'s (NYSE:PRLB) Share Price Doing?
Jun 08Proto Labs (NYSE:PRLB) May Have Issues Allocating Its Capital
May 06Proto Labs Q1 2021 Earnings Preview
May 05Have Insiders Been Selling Proto Labs, Inc. (NYSE:PRLB) Shares?
Mar 19Why Proto Labs, Inc. (NYSE:PRLB) Could Be Worth Watching
Mar 01Proto Labs, Inc.'s (NYSE:PRLB) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?
Feb 09The Trends At Proto Labs (NYSE:PRLB) That You Should Know About
Jan 14Proto Labs Continues To Show Strength
Jan 14Financial Position Analysis
Short Term Liabilities: PRLB's short term assets ($200.7M) exceed its short term liabilities ($49.7M).
Long Term Liabilities: PRLB's short term assets ($200.7M) exceed its long term liabilities ($27.4M).
Debt to Equity History and Analysis
Debt Level: PRLB is debt free.
Reducing Debt: PRLB had no debt 5 years ago.
Debt Coverage: PRLB has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: PRLB has no debt, therefore coverage of interest payments is not a concern.